Telix Pharmaceuticals Limited earnings per share and revenue

A2H7JK earnings per share for the last semiannual are 0.11 EUR whereas the estimation was 0.09 EUR which accounts for 20.00% surprise. Company revenue for the same period amounts to 250.52 M EUR despite the estimated figure of 130.28 M EUR. Estimated earnings per share for the next semiannual are 0.18 EUR, and revenue is expected to reach 325.91 M EUR. Also watch annual changes over time to get a bigger picture of A2H7JK earnings per share and revenue dynamics.